litlas
ログインアカウント作成

Suzanne George

1995–2025 年に発表

131
論文数
18,631
被引用数
74
h 指数
126
i10 指数

被引用数

Suzanne George の年別被引用数1992 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 6 件1999 年: 被引用 9 件2000 年: 被引用 8 件2001 年: 被引用 5 件2002 年: 被引用 5 件2003 年: 被引用 5 件2004 年: 被引用 4 件2005 年: 被引用 11 件2006 年: 被引用 11 件2007 年: 被引用 76 件2008 年: 被引用 80 件2009 年: 被引用 149 件2010 年: 被引用 123 件2011 年: 被引用 103 件2012 年: 被引用 109 件2013 年: 被引用 118 件2014 年: 被引用 122 件2015 年: 被引用 111 件2016 年: 被引用 116 件2017 年: 被引用 137 件2018 年: 被引用 108 件2019 年: 被引用 536 件2020 年: 被引用 542 件2021 年: 被引用 632 件2022 年: 被引用 546 件2023 年: 被引用 398 件2024 年: 被引用 605 件2025 年: 被引用 223 件2026 年: 被引用 4 件1993〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,717 件、この内訳の 27.7%中国: 引用元論文 548 件、この内訳の 8.8%イタリア: 引用元論文 424 件、この内訳の 6.8%フランス: 引用元論文 362 件、この内訳の 5.8%イギリス: 引用元論文 352 件、この内訳の 5.7%ドイツ: 引用元論文 299 件、この内訳の 4.8%オランダ: 引用元論文 235 件、この内訳の 3.8%カナダ: 引用元論文 231 件、この内訳の 3.7%スペイン: 引用元論文 200 件、この内訳の 3.2%日本: 引用元論文 187 件、この内訳の 3%オーストラリア: 引用元論文 138 件、この内訳の 2.2%ベルギー: 引用元論文 122 件、この内訳の 2%
0%27.7%その他 22.5%

機関

分野

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology3.1%
  • Engineering0.5%
  • Chemistry0.3%
  • Computer Science0.3%
  • その他1.9%

トピック

  • Sarcoma Diagnosis and Treatment8.7%
  • Gastrointestinal Tumor Research and Treatment5.2%
  • Endometrial and Cervical Cancer Treatments3.3%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Chemotherapy-induced cardiotoxicity and mitigation2.2%
  • Uterine Myomas and Treatments2.2%
  • その他75.5%

共著者

全論文

検索で開く
  1. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    著者: George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, Martin E. Blackstein, Manisha H. Shah, Jaap Verweij, Grant A. McArthur, Ian Judson, Michael C. Heinrich, Jeffrey A. Morgan, Jayesh Desai, Christopher D.�M. Fletcher, Suzanne George, Carlo L. Bello, Xin Huang, Charles M. Baum, Paolo G. Casali - The Lancet 2006 被引用: 2,595

  2. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    著者: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 被引用: 227

  3. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

    著者: Suzanne George, Diana Miao, George D. Demetri, Dennis O. Adeegbe, Scott J. Rodig, Sachet A. Shukla, Mikel Lipschitz, Ali Amin‐Mansour, Chandrajit P. Raut, Scott L. Carter, Peter S. Hammerman, Gordon J. Freeman, Catherine J. Wu, Patrick A. Ott, Kwok‐Kin Wong, Eliezer M. Van Allen - Immunity 2017 被引用: 485

  4. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

    著者: Michael C. Heinrich, Robin L. Jones, Margaret von Mehren, Patrick Schöffski, César Serrano, Yoon‐Koo Kang, Philippe A. Cassier, Olivier Mir, Ferry A.L.M. Eskens, William D. Tap, Piotr Rutkowski, Sant P. Chawla, Jonathan C. Trent, Meera Tugnait, Erica N Evans, Tamieka Lauz, Teresa Zhou, Maria Roche, Beni B. Wolf, Sebastian Bauer, Suzanne George - The Lancet Oncology 2020 被引用: 304

  5. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 被引用: 407

  6. Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

    著者: Edward S. Kim, Thomas S. Uldrick, Caroline Schenkel, Suanna S. Bruinooge, R. Donald Harvey, Allison Magnuson, Alexander I. Spira, James L. Wade, Mark Stewart, Diana Merino Vega, Julia A. Beaver, Andrea Denicoff, Gwynn Ison, S. Percy Ivy, Suzanne George, Raymond P. Perez, Patricia A. Spears, William D. Tap, Richard L. Schilsky - Clinical Cancer Research 2021 被引用: 111

  7. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

    著者: Tammy F. Chu, Maria A. Rupnick, Risto Kerkelä, Susan M. Dallabrida, David Zurakowski, Lisa Nguyen, Kathleen C. Woulfe, Elke Pravda, Flávia Cassiola, Jayesh Desai, Suzanne George, David M. Harris, Nesreen S. Ismail, Jey-Hsin Chen, Frederick J. Schöen, Annick D. Van den Abbeele, George D. Demetri, Thomas Force, Ming Hui Chen, Jeffrey A. Morgan - The Lancet 2007 被引用: 1,073

  8. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah G Boles, Marilyn M. Bui, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Vicki L. Keedy, Edward Kim, Henry Koon, Joel L. Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Zachary S. Morris, Richard J. O’Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Bernice Ruo, Scott M. Schuetze, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2018 被引用: 733

  9. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    著者: Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Michael C. Heinrich - Journal of Clinical Oncology 2022 被引用: 111

  10. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan A. Higgins, Warner K. Huh, John R. Lurain, Andrea Mariani, David G. Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda N. Fader, Steven W. Remmenga, R. Kevin Reynolds, T. Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2018 被引用: 657

  11. Molecular Subtypes ofKIT/PDGFRAWild-Type Gastrointestinal Stromal Tumors

    著者: Sosipatros A. Boikos, Alberto S. Pappo, J. Keith Killian, Michael P. LaQuaglia, Chris B. Weldon, Suzanne George, Jonathan C. Trent, Margaret von Mehren, Jennifer Wright, J. D. Schiffman, Margarita Raygada, Karel Pacák, Paul S. Meltzer, Markku Miettinen, Constantine A. Stratakis, Katherine A. Janeway, Lee J. Helman - JAMA Oncology 2016 被引用: 407

  12. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

    著者: Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon, Kadija Tahlil, Rita Malley, Melissa Hohos, Kathleen Polson, Margaret Loucks, Mariano Severgnini, Tara Patel, Amy Cunningham, Scott J. Rodig, F. Stephen Hodi, Jeffrey A. Morgan, Priscilla Merriam, Andrew J. Wagner, Geoffrey I. Shapiro, Suzanne George - Cancer 2017 被引用: 223

  13. Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    著者: César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao, Julia Ketzer, Grant Eilers, Mei‐Jun Zhu, Channing Yu, Aristotle M. Mannan, Brian P. Rubin, George D. Demetri, Chandrajit P. Raut, Ajia Presnell, Arin McKinley, Michael C. Heinrich, Jeffrey T. Czaplinski, Ewa Sicińska, Sebastian Bauer, Suzanne George, Jonathan A. Fletcher - British Journal of Cancer 2019 被引用: 166

  14. National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

    著者: Funda Meric‐Bernstam, James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin, Roisin E. O’Cearbhaill, Suzanne George, Julia Glade Bender, Gary H. Lyman, James V. Tricoli, David R. Patton, Stanley R. Hamilton, Robert J. Gray, Douglas S. Hawkins, Bhanumati Ramineni, Keith T. Flaherty, Petros Grivas, Timothy A. Yap, Jordan Berlin, James H. Doroshow, Lyndsay N. Harris, Jeffrey A. Moscow - Clinical Cancer Research 2023 被引用: 59

  15. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

    著者: Margaret von Mehren, John M. Kane, Marilyn M. Bui, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Suzanne George, Ricardo González, Martin J. Heslin, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, I. Benjamin Paz, Ivy A. Petersen, Matthew M. Poppe, Richard F. Riedel, Brian P. Rubin, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Mary Anne Bergman, Giby V. George - Journal of the National Comprehensive Cancer Network 2020 被引用: 303

  16. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    著者: George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón, Angelo Paolo Dei Tos, Jayesh Desai, Jonathan A. Fletcher, Hans Gelderblom, Suzanne George, Alessandro Gronchi, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Ian Judson, Y-K Kang, Akira Kawai, Alexander J. Lazar, Axel Le Cesne, Roberta Maestro, Robert G. Maki, Javier Martín‐Broto, Shreyaskumar Patel, Frédérique Penault‐Llorca, Chandrajit P. Raut, Piotr Rutkowski, Akmal Safwat, Marta Sbaraglia, Inga‐Marie Schaefer, Lin Shen, César Serrano, P. Schöffski, Silvia Stacchiotti, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Jonathan C. Trent, Claudia Valverde, Winette T.A. van der Graaf, M. von Mehren, Andrew J. Wagner, E. Wardelmann, Yoichi Naito, John Zalcberg, Jean‐Yves Blay - Annals of Oncology 2020 被引用: 145

  17. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study

    著者: Yoon‐Koo Kang, Suzanne George, Robin L. Jones, Piotr Rutkowski, Lin Shen, Olivier Mir, Shreyaskumar Patel, Yongjian Zhou, Margaret von Mehren, Peter Hohenberger, Víctor M. Villalobos, Mehdi Brahmi, William D. Tap, Jonathan C. Trent, Maria A. Pantaleo, Patrick Schöffski, Kevin He, Paggy Hew, Kate J. Newberry, Maria Roche, Michael C. Heinrich, Sebastian Bauer - Journal of Clinical Oncology 2021 被引用: 116

  18. Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate

    著者: Kenji Iida, Amr H. Abdelhamid Ahmed, Akiko Kawano Nagatsuma, Tomoko Shibutani, Satoru Yasuda, Michiko Kitamura, Chiharu Hattori, Manabu Abe, Jun Hasegawa, Takuma Iguchi, Tsuyoshi Karibe, Takashi Nakada, Koichiro Inaki, Reiko Kamei, Yuki Abe, Taisei Nomura, Jessica L. Andersen, Sandro Santagata, Matthew L. Hemming, Suzanne George, Toshihiko Doi, Atsushi Ochiai, George D. Demetri, Toshinori Agatsuma - Cancer Discovery 2021 被引用: 50

  19. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021

    著者: Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Elisabeth Diver, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Suzanne George, Robert Giuntoli, Ernest Han, Brooke E. Howitt, Warner K. Huh, Jayanthi Lea, Andrea Mariani, David G. Mutch, Larissa Nekhlyudov, Mirna Podoll, Steven W. Remmenga, R. Kevin Reynolds, Ritu Salani, Rachel Sisodia, Pamela T. Soliman, Edward J. Tanner, Stefanie Ueda, Renata R. Urban, Stephanie L. Wethington, Emily Wyse, Kristine Zanotti, Nicole R. McMillian, Angela D. Motter - Journal of the National Comprehensive Cancer Network 2021 被引用: 173

  20. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

    著者: Robin L. Jones, César Serrano, Margaret von Mehren, Suzanne George, Michael C. Heinrich, Yoon‐Koo Kang, Patrick Schöffski, Philippe A. Cassier, Olivier Mir, Sant P. Chawla, Ferry A.L.M. Eskens, Piotr Rutkowski, William D. Tap, Teresa Zhou, Maria Roche, Sebastian Bauer - European Journal of Cancer 2021 被引用: 136

  21. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

    著者: Michael C. Heinrich, Robin L. Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Brittany L. Siontis, David Goldstein, Kjetil Boye, César Sánchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, César Serrano, Neeta Somaiah, Ping Chi, William M. Reichmann, Kam Sprott, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Jean‐Yves Blay, Sebastian Bauer - Nature Medicine 2024 被引用: 52

  22. Soft Tissue and Uterine Leiomyosarcoma

    著者: Suzanne George, César Serrano, Martee L. Hensley, Isabelle Ray‐Coquard - Journal of Clinical Oncology 2017 被引用: 241

  23. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

    著者: Steven Attia, Vanessa Bolejack, Kristen N. Ganjoo, Suzanne George, Mark Agulnik, Daniel A. Rushing, Elizabeth T. Loggers, Michael B. Livingston, Jennifer Wright, Sant P. Chawla, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Lara E. Davis, Christopher W. Ryan, Robert G. Maki - Cancer Medicine 2022 被引用: 56

  24. Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

    著者: Matthew Ingham, Jacob B. Allred, Li Chen, Biswasjit Das, Bose Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess, ­Mahesh Seetharam, Sosipatros A. Boikos, Nam Q. Bui, James L. Chen, Julia Close, Gregory M. Coté, Premal H. Thaker, S. Percy Ivy, Sminu Bose, Alan D. D’Andrea, Adrián Mariño‐Enríquez, Geoffrey I. Shapiro, Gary K. Schwartz - Journal of Clinical Oncology 2023 被引用: 46